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Abstract
Background: The purpose of this systematic review is to analyse the results of operative treatment for midportion
Achilles tendinopathy and to provide evidence based recommendation for the indication of the individual
published techniques.
Methods: MEDLINE, Cochrane Database, ISI Web of Knowledge and Google databases (1945 till September 2014)
were electronically searched. The quality of the included articles was evaluated using the Coleman Methodology
Score. Success rates, patient satisfaction, and the complication rates were determined.
Results: Twenty studies met our inclusion criteria. A total of 801 tendons were treated in 714 patients with open or
minimally invasive techniques. The mean success rate was 83.4 %. Complications were reported in 6.3 % of the
cases. The articles on minimally invasive techniques and open procedures reported on an average success rate of
83.6 % and 78.9 (p = 0.987). Patient satisfaction rates for minimally invasive techniques and open procedures were
78.5 % and 78.1 % (p = 0.211). The complication rate was 5.3 % for the minimally invasive techniques and 10.5 % for
the open procedures (p = 0.053).
Conclusion: We conclude that success rates of minimally invasive and open treatments are not different and that there
is no difference in patient satisfaction but there is a tendency for more complications to occur in open procedures.
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Background
Midportion Achilles tendinopathy is a wide-spread dis-
order with a prevalence of 2.01 per 1,000 patients [1]. Its
aetiology is thought to be associated with multiple factors
including overuse, poor vascularity, a lack of flexibility,
genetic makeup, gender, endocrine, a high body mass
index or metabolic factors [1–7]. Historically, the termin-
ology for midportion Achilles tendinopathy was not con-
sistent. We adopted the recently suggested definition: “a
clinical syndrome characterized by a combination of pain,
swelling and impaired performance” [8]. Midportion
Achilles tendinopathy is located about 2–6 cm proximal
to the Achilles tendon insertion onto the calcaneus
[6, 9]. The painful region coincides with the tendon
area possessing the poorest blood supply [4, 5, 10].
The “tendon pathology continuum model” describes a
discrepancy between load in relation to intrinsic factors
like genetics, adiposity, cholesterol, and diabetes finally
leading to degeneration and insufficient regenerative
capability of an individual Achilles tendon [11]. In the
literature, several hypotheses have been established to
explain the cause of pain in Achilles tendinopathy [12].
Besides intratendineous degeneration (tendinosis), neo-
vascularization and neurogenic inflammatory processes
seem to play a major role with pain representing the
“tip of the iceberg” [12].
Much has been published about the conservative treat-
ment of midportion Achilles tendinopathy [13–16]. Con-
servative modalities include load modification, eccentric
exercises, orthoses, massage, electrotherapy, cryotherapy,
nonsteroidal anti-inflammatory drugs, extracorporeal
shockwave therapy (ESWT), high volume and sclerosing
injections [5, 17]. However, about 25 % of the patients
present with remaining symptoms after conservative
treatment [6, 7, 14–16, 18]. For these patients, operative
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intervention is indicated [5, 6, 17, 19]. According to the
“tendon pathology continuum model” [11] and to recent
pathogenic considerations [12] two principally different op-
erative approaches and their combinations can be identi-
fied. Intratendineous lesions (tendinosis) or/and the pain
producing or pain transmitting neurogenic structures out-
side the Achilles tendon are addressed. Specifically, the pro-
cedures address (a) removal of the abnormal tissue inside
the Achilles tendon and the paratenon, (b) activation of the
regenerative process by scarification of the Achilles tendon,
(c) vascular disruption, (d) gastrocnemius recession to re-
duce the tension and therefore the overload of the Achilles
tendon, and (e) if the quality of the tendinopathic Achilles
tendon is poor (more severe cases), a transfer of an intact
tendon (Flexor hallucis longus) can be performed [10, 20].
In 2001, a “critical review” for the operative treatment of
midportion Achilles tendinopathy and in 2015 a sys-
tematic review for “outcomes for insertional and non-
insertional Achilles tendinopathy surgery” were published
[20, 21]. However, there is no systematic review available
for operative treatment of midportion Achilles tendinopa-
thy considering the different operative techniques.
The aim of this study is therefore, to systematically re-
view the literature for operative treatment of midportion
Achilles tendinopathy. It is hypothesized that operative
approaches are effective for midportion Achilles tendino-
pathy not responding to first line conservative treatment.
Additionally, it is questioned if a specific open or minim-
ally invasive operative technique can be considered to be
superior when comparing results and complications.
Methods
Search strategy
MEDLINE, Cochrane Database, ISI Web of Knowledge and
Google were systematically searched by two reviewers using
the terms: (achilles tendinopathy OR achilles tendopathy
OR achillodynia OR achillodynie OR tendinopathy OR
tendo achilles OR achilles tendon OR achilles tendinosis
OR achilles tendonosis OR tendinosis) AND ((midportion
OR mid-portion OR non-insertional OR main body OR
central core OR noninsertional OR mid portion OR percu-
taneous longitudinal tenotomy OR flexor hallucis longus
transfer OR FHL OR gastrocnemius recession OR gastro-
cnemius lengthening OR paratenon release OR achilles
tendinoscopy OR debridement) AND (surgery OR surgical
OR surg OR operative OR operation OR treatment) NOT
calcaneal bursitis OR bursitis OR hagland OR haglund OR
insertional)) Filters: Publication date to 2014/09/31. The
Cochrane Database of Clinical and Randomized Controlled
Trials was additionally searched using the term “Achilles”.
The Google Scholar search was performed by using the
keywords “Achilles tendinopathy” surgery -“calcaneal bur-
sitis” -bursitis -hagland -haglund –insertional.
Data collection and study selection
The procedure was based on the PRISMA guidelines for
reporting systematic reviews and meta‐analyses [22].
Two reviewers independently evaluated the titles and ab-
stracts of the identified publications and the selected full
text manuscripts in an unblinded standardized manner
and excluded irrelevant articles (reviews, cadaver studies,
technical descriptions). Disagreements between reviewers
were resolved by consensus. Articles in English and Ger-
man language were included. Differences remaining be-
tween the reviewers concerning inclusion of studies were
discussed and consensus was obtained (3 cases).
Inclusion criteria
We included prospective clinical studies reporting on
the subjective, clinical, or functional outcome of opera-
tive treatment for midportion Achilles tendinopathy.
Studies had to characterize the clinical syndrome by
pain, swelling and impaired performance. Results from
studies reporting on adult patients (age over 18 years)
with midportion Achilles tendinopathy were included.
Exclusion criteria
Studies, dealing with the treatment of Achilles tendon
ruptures, insertional Achilles tendinopathy, retrocalca-
neal bursitis/Haglund’s disease and superficial calcaneal
bursitis were excluded. Studies which used an incon-
sistent terminology were excluded since the treated
condition was not unequivocally midportion Achilles
tendinopathy. We didn’t consider case series with less
than five patients. Articles on expert opinion, reviews,
those with retrospective design and unidentified out-
come measures were also excluded. If different tech-
niques were reported in one study and the results were
not specified with respect to the used technique, we de-
cided to exclude these data for the subgroup analysis.
Studies which did not report on one of the required
main outcome measures were not included in the spe-
cific calculations.
Data extraction and quality assessment
We extracted outcome data using the Coleman method-
ology scale (CMS) [23]. By this it was possible to meas-
ure the methodological quality of the included studies.
The score ranges between 0 and 100. A score of 100
represents a perfect study design that largely avoids the
influence of chance, different biases, and confounding
factors. As primary outcome criteria the results of the
studies were classified referring to the “functional
classification of postsurgical outcome for Achilles tendi-
nopathy” as excellent, good, fair, or poor [20, 24]. This
categorical and disease specific rating scale was devel-
oped for evaluation of outcome after Achilles tendinopa-
thy operations. An excellent result indicates no residual
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symptoms and unlimited sport performance. Good means
full sport ability but “some stiffness after strenuous activ-
ities”. Fair is rated when there is improvement but still
“stiffness and aching” related to sport activities. “No im-
provement at all” is considered poor. Even if the reliability
and validity of this tool has not formally been analysed, it
has been used to evaluate outcome in most of our reviewed
studies. Excellent and good results sum up to the success
rate [20]. Previous Achilles tendinopathy reviews reported
improvement of methodological quality and a negative cor-
relation between success rates during the reviewed periods
[20, 21]. Respectively, we also correlated the CMS with
operative success rate (%) and the year of publication.
Secondary outcome criteria were patient’s satisfaction and
complications related to the performed operations.
Patient’s satisfaction is a subjective rating of the patients.
The complication rate sums up wound infections, scar
hypersensitivity in the operative field, hypertrophic scars,
skin necrosis and fibrotic reactions, the need of further sur-
gery, or Achilles tendon ruptures, as well as deep vein
thrombosis and/or lung embolism. For analysis the results
of the included studies were pooled referring to the used
techniques (see grouping). This led to a main group
analysis (open vs. minimally invasive) and to a subgroup
analysis (open release of adhesions with or without resec-
tion of the paratenon, open debridement of tendinopathic
areas through a central longitudinal tenotomy, flexor
hallucis longus (FHL) transfer, longitudinal tenotomy,
gastrocnemius lengthening or recession, percutaneous
longitudinal tenotomy, minimally invasive debridement).
Grouping
In the initial part of the analyses and based on a recently
published instructional review [15] we pooled the ex-
tracted data in two groups (open techniques and minim-
ally invasive techniques). A technique was classified as
minimally invasive, if the length of a single incision was
less than 1 inch (2.5 cm). The open procedures group in-
cluded longitudinal tenotomies with debridement of the
diseased area of the tendon with or without tendon aug-
mentation, and gastrocnemius lengthening or recession.
The minimally invasive group included percutaneous lon-
gitudinal tenotomies, endoscopic debridement or scraping
with or without the augmentation of the flexor hallucis
longus or the plantaris tendon, and minimally invasive
gastrocnemius lengthening or recession.
For the subgroup analysis we pooled the data in six
groups: open peritendineous debridement = open release
of adhesion with or without resection of the paratenon,
open intratendineous debridement = open debridement of
tendinopathic areas through a central longitudinal tenot-
omy, FHL transfer/augmentation, gastrocnemius length-
ening or recession, percutaneous longitudinal tenotomy,
and minimally invasive paratenon debridement.
Statistical analysis
For the statistical analysis IBM SPSS 21 was used.
Operative methods were compared by descriptive statis-
tics (weighted means and standard deviations). All data
were checked for normal distribution. The level of
significance was defined at p = 0.05. We compared the re-
sults of the different techniques in two steps. In a first step
the results of open and minimally invasive techniques
(main group/outcome) were compared. In a second step
subgroups (six specific techniques) were compared (open
peritendineous debridement, open intratendineous de-
bridement, FHL tendon transfer/augmentation, gastrocne-
mius lengthening or recession, percutaneous longitudinal
tenotomy, and minimally invasive paratenon debride-
ment). A Breslow-Day-Test was used to compare the
odds’ ratio of the correlation between the different tech-
niques. After that a Mantel-Haenszel-chi-squared test was
used to compare the outcome of the different techniques.
A Bonferroni-Holm-Test was used for the post-hoc test.
Pearson correlation was calculated between the CMS and
the success rate and the CMS and the year of publication.
Results
Study selection
A total of 4453 studies were electronically identified for
inclusion in the review. After adjusting for duplicates 4378
potentially relevant studies remained. After reviewing the
titles and abstracts 4302 of these studies were discarded
because it appeared that these papers clearly did not meet
the criteria. The full text of the remaining 76 papers was
obtained and examined in more detail. Fifty-six studies
did not meet the inclusion criteria as described. The hand
search of the references identified one more relevant art-
icle which was not detected from the electronic search.
Twenty-one articles were considered to be relevant and
the respective full texts were further analysed. Three
authors of the included studies were contacted by email to
obtain further detailed information which was not pre-
sented in their publications [18, 25, 26].
One group of researchers [27] published results once in
1997 and an update in 2013 [28]. We only included the up-
dated results. Finally, 20 articles remained and served as the
database for this review (Fig. 1) [4, 18, 19, 24–26, 28–41].
Population characteristics
The total number of patients with Achilles tendinopathy
in the 20 included studies was 714 and 801 tendons
were treated. Eight of the included studies treated 388
patients with bilateral midportion Achilles tendinopathy
[4, 24, 25, 30, 32, 36, 38, 41]. The mean age of the
patients was 46.6 years (range 28.7 to 61). There were
61 % males and 39 % females. Seven studies did not
report patient characteristics or did not state them
clearly regarding age and gender [18, 26, 28, 31, 32, 34].
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Three studies reported different results for variable pop-
ulations [25, 34, 35]. One compared the results of female
and male patients and reported both a higher success
rate and a lower complication rate in males [35]. In two
other studies the authors showed that athletic patients
recovered with a higher success rate accompanied by a
lower complication rate compared to non-athletic pa-
tients [25, 34].
Preoperative treatment
Preoperatively, all patients underwent conservative
treatment for at least three months. The reported con-
servative treatments included immobilization, eccentric
exercise, stretching, cryotherapy, ultrasound therapy,
laser therapy, orthotics, extracorporeal shock wave ther-
apy, sclerosing injections, and anti-inflammatory medi-
cation [4, 18, 19, 24–26, 28–41].
Grouping
The open procedure group (542 patients) included lon-
gitudinal tenotomies with debridement of the diseased
area of the tendon with or without tendon augmentation
(537 patients) [4, 18, 19, 24, 29, 32, 34, 35, 37, 41] and
gastrocnemius lengthening or recession (5 patients,Table 1)
[31]. The minimally invasive group (172 patients) included
percutaneous longitudinal tenotomies (47 patients) [28, 40],
endoscopic debridement or scraping with or without aug-
mentation of the flexor hallucis longus or the plantaris
tendon (111 patients) [25, 26, 33, 38, 39, 42] and
minimally invasive gastrocnemius lengthening or reces-
sion (14 patients) [30].
The subgroups analyses revealed 109 patients treated
with open peritendineous debridement [18, 24], 96
patients had open intratendineous debridement [18, 19,
24, 32], 152 patients had FHL transfer/augmentation
Fig. 1 Prisma flowchart [22] of the data collection and study selection progress
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[24, 29, 33, 37, 41], 19 patients had gastrocnemius
lengthening or recession [30, 31], 126 patients had
percutaneous longitudinal tenotomy [25, 28], and 106
patients had minimally invasive paratenon debride-
ment [25, 26, 38, 40, 42] (Table 2). Two studies treated
patients with different techniques but did not clearly
enough state the results and were therefore not included
in the subgroup analysis [34, 35]. Two studies presented
cohorts treated with different operative techniques (percu-
taneous longitudinal tenotomy and minimally invasive
paratenon debridement) [24, 25]. One of these studies
specified the number of patients only for the whole group.
For the performed operative techniques only the numbers
of Achilles tendons are presented. For this specific case,
we decided to incorporate the number of treated Achilles
tendons in our subgroup analyses [24].
Methodological quality
The mean CMS of all reviewed articles was 70.1 (range
53 to 84). We found no significant correlation
between the CMS and the reported success rates (r = 0.04;
p = 0.17). The correlation between the CMS and the year
of publication was (r = 0.42, p = 0.07).
Operative techniques
The mean success rate for all procedures was 83.4 %
(range 66 to 100 %). Four studies didn’t report on the
success rate (Table 1) [26, 29, 31, 38].The overall patient
satisfaction was 77.5 % (range 60 to 95 %) and the com-
plication rate was 6.3 % (range 0 to 23 %). In 2.4 % of
the cases reoperation was necessary. In three cases
(0.4 %) a total tendon rupture occurred during postoper-
ative rehabilitation [4, 24, 25].
Open procedures
The results of open techniques were reported in 11 stud-
ies (604 tendons in 542 patients). The mean success rate
was 78.9 % (range 66 to 100). The mean patient satisfac-
tion rate was 78.1 % (range 66 to 95). The mean
Table 1 Results of the reviewed literature for open and minimally invasive procedures
Year CMS N Age FU SR PS CR
Open techniques
Rolf et al. [4] 1997 60 58 40 25 75 n.s 13
Nelen et al. [24] 1989 66 91 30 48 85 n.s 7
Cottom et al. [29] 2008 81 62 61 27 n.s 95 23
Wilcox et al. [41] 2000 58 17 61 14 75 n.s 0
Martin et al. [37] 2005 84 44 58 41 91 86 11
Alfredson et al. [19] 2007 53 10 45 6 100 80 10
Lohrer & Nauck [32] 2014 81 34 50 12 97 n.s 8
Paavola et al. [18] 2002 59 42 42 7 83 87 6
Maffulli et al. [34] 2006 75 93 n.s 37 66 68 9
Maffulli et al. [35] 2008 75 86 n.s 40 73 69 10
Gurdezi et al. [31] 2013 70 5 45 30 n.s 66 n.s
69.3 ± 10.7 542 45.6 ± 10.5 32.0 ± 14.6 78.9 ± 11.5 78.1 ± 11.3 10.5 ± 5.9
Minimally invasive techniques
Duthon et al. [30] 2011 64 14 42 24 79 60 0
Maquirriain [42] 2013 79 24 46 92 100 n.s 7
Lui [33] 2012 69 5 46 20 80 n.s 0
Thermann et al. [39] 2009 69 8 52 6 80 80 0
Maffulli et al. [28] 2013 84 39 45 204 77 77 18
Pearce et al. [26] 2011 62 11 37 30 n.s 72 0
Vega et al. [40] 2008 69 8 43 27 100 n.s 0
Alfredson [25] 2011 73 16 47 18 74 74 3
Ruergård & Alfredson [38] 2014 79 47 52 12 n.s 88 0
72.0 ± 7.4 172 46.7 ± 4.7 70.0 ± 63.6 83.6 ± 10.9 78.5 ± 9.3 5.3 ± 6.1
Year of publication (Year), Coleman Methodological Score (CMS), Number of patients (N), Age (years), Followup period (FU) in months , Success rate (SR) in %, Patient
satisfaction (PS) in %, and Complication rates (CR) in %. Values for FU, SR, and PS of the individual studies are presented as means. N.s. = not specified. Summarized
information of the open and minimally invasive techniques studies are presented in the last lines of the respective sections (CMS = unweighted mean. Age, FU, SR, PS,
and CR =weighted means ± SD)
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complication rate was 10.5 % (range 0 to 23) (Table 1)
[4, 17, 19, 24, 29, 31, 32, 34, 35, 37, 41].
Minimally invasive techniques
Minimally invasive techniques were reported in nine
studies (198 tendons in 172 patients). The mean success
rate was 83.6 % (range 74 to 100). The mean patient sat-
isfaction rate was 78.5 % (range 60 to 88). Complications
occurred in 5.3 % of the cases (range 0 to 18; Table 2)
[25, 26, 28, 30, 33, 36, 38–40].
Comparison of the techniques
Statistically, no difference was found between open and
minimally invasive procedures regarding success rates
(78.9 % and 83.6 %; p = 0.987) and patient satisfaction
(78.1 % and 78.5 %; p = 0.211). Studies on open tech-
niques reported a tendency to more complications than
the studies on minimally invasive techniques (9.7 % and
3.1 %; p = 0.053) (Table 1).
The subgroup analyses for the success rates demon-
strated superiority of minimally invasive paratenon
Table 2 Results of the reviewed literature for the specific operative techniques
Year CMS N Age FU SR PS CR
Open peritendineous debridement
Nelen et al. [24]a 1989 66 93 n.s. n.s. 88 n.s. n.s.
Paavola et al. [18] 2002 59 16 37 7 100 94 6
62.5 ± 4.9 109 37 7 89.8 ± 8.5 94 6
Open intratendineous debridement
Nelen et al. [24]a 1989 66 26 n.s. n.s. 73 n.s. n.s.
Alfredson et al. [19] 2007 53 10 45 6 100 80 10
Lohrer & Nauck [32] 2014 81 34 50 12 97 n.s. 8
Paavola et al. [18] 2002 59 26 46 7 73 79 27
64.8 ± 12.1 96 47.8 ± 2.6 6.8 ± 4.9 84.3 ± 14.8 79.3 ± 0.7 15.3 ± 10.4
FHL transfer/augmentation
Nelen et al. [24] 1989 66 24 n.s. n.s. 87 n.s. n.s.
Cottom et al. [29] 2008 81 62 61 27 n.s. 95 23
Wilcox et al. [41] 2000 58 17 61 14 75 n.s. 0
Martin et al. [37] 2005 84 44 58 41 91 86 11
Lui et al. [33] 2012 69 5 46 20 80 n.s. 0
71.6 ± 10.8 152 59.4 ± 7.1 29.8 ± 11.6 86.3 ± 7.1 91.3 ± 6.4 14.9 ± 11.0
Gastrocnemius recession
Duthon et al. [30] 2011 64 14 42 24 79 60 0
Gurdezi et al. [31] 2013 70 5 45 30 n.s. 66 n.s.
67.0 ± 4.2 19 42.8 ± 2.1 25.6 ± 4.2 79.0 61.6 ± 4.2 0.0
Percutaneous longitudinal tenotomy
Alfredson et al. [25] 2011 73 87 46 18 83 83 3
Maffulli et al. [28] 2013 84 39 45 204 77 77 18
78.5 ± 7.8 126 45.7 ± 0.7 75.6 ± 131.6 81.1 ± 4.2 81.1 ± 4.2 7.6 ± 10.6
Minimally invasive paratenon debridement
Maquirriain et al. [42] 2013 79 24 46 92 100 n.s. 7
Pearce et al. [26] 2012 62 11 37 30 n.s. 72 0
Vega et al. [40] 2008 69 8 43 27 100 n.s. 0
Alfredson et al. [25] 2011 73 16 47 18 74 74 3
Ruergård & Alfredson [38] 2014 79 47 52 12 n.s. 88 0
72.4 ± 7.2 106 47.7 ± 5.5 34.0 ± 32.2. 91.3 ± 15.0 82.6 ± 8.7 2.0 ± 3.1
Year of publication (Year), Coleman Methodological Score (CMS), Number of patients (N), aFor this study N means number of tendons, Age (years), Followup
period (FU) in months, Success rate (SR) in %, Patient satisfaction (PS) in %, and Complication rates (CR) in %. Values for FU, SR, and PS of the individual studies
are presented as means. Summarized information of the specific operative techniques are presented in the last lines of the respective sections (CMS =
unweighted mean. Age, FU, SR, PS, and CR = weighted means ± SD)
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debridement compared with percutaneous longitudinal
tenotomy (p = 0.036). All other success rates compari-
sons were not statistically different (p = 0.083 to 0.916,
Table 3). Higher patient satisfaction rates were detected
for open paratenon debridement (94 %) compared with
open intratendineous debridement (79.3 %, p < 0.003),
gastrocnemius recession (61.6 %, p < 0.0001), per-
cutaneous longitudinal tenotomy (81.1 %, p = 0.008),
and minimally invasive paratenon debridement (82.5 %,
p < 0.028). FHL tendon transfer/augmentation (91.3 %)
was associated with a higher patient satisfaction rate than
open intratendineous debridement (79.3 %, p = 0.006),
gastrocnemius recession/lengthening (61.6 %, p = 0.001)
and percutaneous longitudinal tenotomy (81.1 %, p = 0.017).
The complication rates for FHL tendon transfer/augmen-
tation (14.9 %) was higher than for open paratenon
debridement (6 %, p = 0.048) and for minimally invasive
paratenon debridement (2.0 %, p = 0.001; Table 2).
Post-operative treatment
All studies but two [26, 33] reported on the postoperative
treatment. The authors of open procedures allowed
weight bearing after 2 weeks [19, 34], recommended the
wearing of a cast for more than 6 weeks [4, 29, 32, 37, 41],
and allowed competitive sports after two to six months
[18, 24, 34, 35]. The authors of minimally invasive
procedures recommended full weight bearing after one
[36] to two weeks [19, 25, 31, 38–40], wearing of a cast for
6 weeks [28] and sports activity after 6 weeks [28] to three
month [30].
Discussion
This study systematically evaluates the literature for the
effectiveness of operative treatment in patients with
midportion Achilles tendinopathy. The analyses are
based on success rates, patient satisfaction, and compli-
cation rates.
The most important finding of our study is that operative
treatment is a successful option for midportion Achilles
tendinopathy recalcitrant to non-operative treatment.
Overall, this finding mirrors exactly the results of another
recent systematic review (83.4 % vs. 83.5 %) [21]. That re-
view, however, is biased by including also retrocalcaneal
bursitis and case reports. A systematic review for retrocal-
caneal bursitis surgery presented success rates of 91 % for
endoscopic and 73 % for open procedures [43]. Our results
are superior to a critical Achilles tendinopathy review from
2001 (mean success rate = 77 %) [20].
We specifically addressed midportion Achilles tendi-
nopathy. Depending from the used technique, success
rates vary between 73 and 100 %. Even if the reviewed
literature did not definitely describe the pathologic stage
of the treated tendons, one could argue that more ad-
vanced stages of Achilles tendon degeneration will lead
the treating surgeon to indicate more complex operative
treatments. In practice a surgeon would not randomly
choose between minimally invasive tendon debridement
and FHL augmentation but would choose the latter pro-
cedure for a more severe case. Consequently, different
stages of Achilles tendon lesions may differ in their re-
sponse to a specific operative technique; e.g. advanced
Table 3 Results of the statistical comparisons between the reviewed groups of different operative procedures
SR PS CR
Open procedures vs. Minimally invasive procedures 0.987 0.211 0.053
Open peritendineous debridement vs. Open intratendineous debridement 0.250 0.003a 0.062
FHL transfer/augmentation 0.477 0.688 0.048a
Gastrocnemius recession 0.327 0.0001a 0.557
Percutaneous longitudinal tenotomy 0.083 0.008a 0.846
Minimally invasive paratenon debridement 0.866 0.028a 0.188
Open intratendineous debridement vs. FHL transfer/augmentation 0.692 0.006b 0.913
Gastrocnemius recession 0.882 0.264 0.145
Percutaneous longitudinal tenotomy 0.752 0.756 0.121
Minimally invasive paratenon debridement 0.130 0.507 0.160
FHL transfer/augmentation vs. Gastrocnemius recession 0.620 0.001a 0.144
Percutaneous longitudinal tenotomy 0.311 0.017a 0.097
Minimally invasive paratenon debridement 0.266 0.064 0.001b
Gastrocnemius recession vs. Percutaneous longitudinal tenotomy 0.916 0.145 0.433
Minimally invasive paratenon debridement 0.215 0.095 0.698
Percutaneous longitudinal tenotomy vs. Minimally invasive paratenon debridement 0.036b 0.814 0.077
Significant findings are presented in bold. The first line relates to Table 1. The rest of the table represents findings from Table 2. aThe significant value favours the
technique which is described in the first column. bThe significant value favours the technique which is described in the second column
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stages of Achilles tendon degeneration with impaired
tendon quality may in principle be better treated with an
augmentation, while an isolated minimally invasive
paratenon debridement may not be sufficient for that
advanced pathology. Most minimally invasive techniques
focus mainly the peritendineous tissues and intend to
eliminate neovascularization with its accompanying
nerves as a cause of pain and disease progression [10].
So, minimally invasive approaches in principle address
pain, while open techniques aim to treat the degenerated
tendon tissue. For the results of the analyses of the
different operative techniques (subgroup analyses), a
respective selection bias has to be stated. Considering
these limitation this systematic review shows that there
is no statistical difference between open procedures and
the minimally invasive techniques regarding success
rates (78.9 % vs. 83.6 %; p = 0.987) and patient satisfac-
tion (78.1 % vs. 78.5 %; p = 0.211), but the complication
rate is tendentially higher following open surgery
(10.5 % vs. 5.3 %; p = 0.053).
The subgroup analysis showed superiority of the minim-
ally invasive paratenon debridement over percutaneous
longitudinal tenotomy (91.3 % vs. 81.1 %; p = 0.036). The
higher patient satisfaction and lower complication rates
following paratenon debridement (Table 3) are based on
only one report and therefore needs further substantiation
in future research. Lowest success rates are presented for
gastrocnemius recession (61.6 %; Table 3). Comparison of
the complication rates favored minimally invasive parate-
non debridement (2.0 %; Tables 2 and 3).
According to previous reports we decided to use the
CMS to make outcomes comparable [25, 44]. A previous
critical review on operative midportion Achilles tendino-
pathy treatment reported on a mean CMS of 37.6 (range
2 to 74) [20] while another systematic review included
both, Achilles tendinopathy and retrocalcaneal bursitis
and found a mean CMS of 40.1 (range 2 to 79). As a
result of our more strict inclusion criteria the studies
included in the present investigation reached a mean
score of 70.5 (range 51 to 85). Previously, the methodo-
logical quality of the midportion Achilles tendinopathy
research has been shown to directly influence the re-
ported outcome [20, 21] and an increase in the CMS
was connected with a decrease in the reported success
rate. In our systematic review, however, CMS and success
rate did not correlate significantly (r = 0.04; p = 0.17).
A positive linear correlation between the CMS and the
year of publication was also previously stated [20, 21].
This means that the quality of the published articles
were thought to increase over the time. Our analyses
found a trend in the same direction (r = 0.42, p = 0.07).
One reason for missing the significance level may be
that our data were based on material mainly from the
past 12 years, representing a time period of generally
higher methodological quality research. Additionally,
case reports and small case series were excluded in our
review.
Three studies reported different results for subpo-
pulations and reported higher success and lower com-
plication rates for male patients and also for athletic
patients [25, 34, 35].
Strengths of this systematic review are the strict inclu-
sion criteria and the fact that all the included studies
were prospective.
Randomized comparisons between open and minim-
ally invasive procedures referring to the same severity/
grade of Achilles tendinopathy are still missing and
should be performed in the future and meta-analyses are
required to definitely demonstrate the worth of the dif-
ferent techniques [45]. Even if we tried to detect all rele-
vant articles in our search algorithm, studies may have
been excluded based on their choice of terminology. A
similar criticism relates to the post-operative treatment.
The short followup period of several studies is another
concern. In studies on conservative treatment followup
periods with more than five years [44] are available,
while the shortest followup period in our included stud-
ies was six month [19]. For the classification of results
authors often used questionnaires which were not region
specific or validated [46–49] and this detail could also
bias the results and has to be adequately addressed in fu-
ture research. In the future researchers should use valid,
reliable, and sensitive outcome measures like the VISA-A
questionnaire [47] to longitudinally and objectively quan-
tify the effects of their interventions. We demand ran-
domized controlled studies focusing on the sole effect of
operative treatments. This would allow being more
conclusive regarding the best applicable treatment for a
specific patient suffering from recalcitrant midportion
Achilles tendinopathy.
Conclusion
Operative treatments seem to be a good option for mid-
portion Achilles tendinopathy patients, when conserva-
tive treatment fails.
Resulting from the lower complication rate, this sys-
tematic review recommends minimally invasive surgery
as the primary operative treatment option. However, a
stage adapted procedure is recommended.
Ethics and consent to participate




Lohrer et al. BMC Musculoskeletal Disorders  (2016) 17:207 Page 8 of 10
Availability of data and materials
All the data supporting our findings is contained within
the manuscript.
Abbreviations
CMS: Coleman methodology scale; ESWT: Extracorporeal Shock Wave
Therapy; FHL: Flexor hallucis longus; VISA-A: Victorian institute of sports
assessment–Achilles tendon; Vs.: versus.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
HL conceived the study, participated in its design, performed data acquisition,
interpreted the data and drafted the manuscript. SN conceived the study,
participated in its design, performed data acquisition, analyzed and interpreted
the data and helped to draft the manuscript. TN conceived the study,
participated in its design, analyzed and interpreted the data, and helped to
draft the manuscript. All authors read and approved the final manuscript
Acknowledgements
This paper was presented in part at the 3rd European College of Sports and
Exercise Physicians conference (Frankfurt am Main/Germany) and was
awarded with the Young Investigator Award.
The authors thank Dr. H. Ackermann (Institut für Biostatistik und Mathematische
Modellierung, Zentrum der Gesundheitswissenschaften, Klinikum und
Fachbereich Medizin der Goethe-Universität Frankfurt am Main, Germany) for
his statistical support.
Funding
No funding was obtained for this study.
Author details
1ESN – European Sportscare Network, Zentrum für Sportorthopädie,
Borsigstrasse 2, 65205 Wiesbaden-Nordenstadt, Germany. 2Department of
Sport and Sport Science, University of Freiburg, Schwarzwaldstraße 175,
79117 Freiburg, Germany. 3Deutsche Sporthochschule Köln, Am Sportpark
Müngersdorf 6, 50933 Köln, Germany.
Received: 19 December 2015 Accepted: 7 May 2016
References
1. de Jonge S, van den Berq C, de Vos RJ, van der Heide HJ, Weir A, Verhaar JA,
et al. Incidence of midportion Achilles tendinopathy in the general population.
Br J Sports Med. 2011;45:1026–8.
2. Klein EE, Weil Jr L, Weil Sr LS, Fleischer AE. Body mass index and achilles
tendonitis: a 10-year retrospective analysis. Foot Ankle Spec. 2013;6:276–82.
3. Maffulli N, Kader D. Tendinopathy of tendo achillis. J Bone Joint Surg Br.
2002;84:1–8.
4. Rolf C, Movin T. Etiology, histopathology, and outcome of surgery in
achillodynia. Foot Ankle Int. 1997;18:565–9.
5. Rompe JD, Furia JP, Maffulli N. Mid-portion Achilles tendinopathy–current
options for treatment. Disabil Rehabil. 2008;30:1666–76.
6. Scott AT, Le IL, Easley ME. Surgical strategies: noninsertional Achilles
tendinopathy. Foot Ankle Int. 2008;29:759–71.
7. Silbernagel KG, Brorsson A, Lundberg M. The majority of patients with
Achilles tendinopathy recover fully when treated with exercise alone:
a 5-year follow-up. Am J Sports Med. 2011;39:607–13.
8. Khan KM, Cook JL, Kannus P, Maffulli N, Bonar SF. Time to abandon the
“tendinitis” myth. BMJ. 2002;324:626–7.
9. van Dijk CN, van Sterkenburg MN, Wiegerinck JI, Karlsson J, Maffulli N.
Terminology for Achilles tendon related disorders. Knee Surg Sports
Traumatol Arthrosc. 2011;19:835–41.
10. Longo UG, Ramamurthy C, Denaro V, Maffulli N. Minimally invasive stripping
for chronic Achilles tendinopathy. Disabil Rehabil. 2008;30:1709–13.
11. Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology
model to explain the clinical presentation of load-induced tendinopathy.
Br J Sports Med. 2009;43:409–16.
12. Magnan B, Bondi M, Pierantoni S, Samaila E. The pathogenesis of Achilles
tendinopathy: a systematic review. Foot Ankle Surg. 2014;20:154–9.
13. Cook JL, Khan KM, Purdam C. Achilles tendinopathy. Man Ther. 2002;7:121–30.
14. Magnussen RA, Dunn WR, Thomson AB. Nonoperative treatment of
midportion Achilles tendinopathy: a systematic review. Clin J Sport Med.
2009;19:54–64.
15. Roche AJ, Calder JD. Achilles tendinopathy: A review of the current
concepts of treatment. Bone Joint J. 2013;95-B:1299–307.
16. Sussmilch-Leitch SP, Collins NJ, Bialocerkowski AE, Warden SJ, Crossley KM.
Physical therapies for Achilles tendinopathy: systematic review and
meta-analysis. J Foot Ankle Res. 2012;5:15.
17. Andres BM, Murrell GA. Treatment of tendinopathy: what works, what does
not, and what is on the horizon. Clin Orthop Relat Res. 2008;466:1539–54.
18. Paavola M, Kannus P, Orava S, Pasanen M, Jarvinen M. Surgical treatment for
chronic Achilles tendinopathy: a prospective seven month follow up study.
Br J Sports Med. 2002;36:178–82.
19. Alfredson H, Ohberg L, Zeisig E, Lorentzon R. Treatment of midportion
Achilles tendinosis: similar clinical results with US and CD-guided surgery
outside the tendon and sclerosing polidocanol injections. Knee Surg Sports
Traumatol Arthrosc. 2007;15:1504–9.
20. Tallon C, Coleman BD, Khan KM, Maffulli N. Outcome of surgery for chronic
Achilles tendinopathy. A critical review. Am J Sports Med. 2001;29:315–20.
21. Khan WS, Malvankar S, Bhamra JS, Pengas I. Analysing the outcome of
surgery for chronic Achilles tendinopathy over the last 50 years. World J
Orthop. 2015;6:491–7.
22. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al.
The PRISMA statement for reporting systematic reviews and meta-analyses
of studies that evaluate healthcare interventions: explanation and
elaboration. BMJ. 2009;339:b2700.
23. Coleman BD, Khan KM, Maffulli N, Cook JL, Wark JD. Studies of surgical
outcome after patellar tendinopathy: clinical significance of methodological
deficiencies and guidelines for future studies. Victorian Institute of Sport
Tendon Study Group. Scand J Med Sci Sports. 2000;10:2–11.
24. Nelen G, Martens M, Burssens A. Surgical treatment of chronic Achilles
tendinitis. Am J Sports Med. 1989;17:754–9.
25. Alfredson H. Ultrasound and Doppler-guided mini-surgery to treat
midportion Achilles tendinosis: results of a large material and a randomised
study comparing two scraping techniques. Br J Sports Med. 2011;45:407–10.
26. Pearce CJ, Carmichael J, Calder JD. Achilles tendinoscopy and plantaris
tendon release and division in the treatment of non-insertional Achilles
tendinopathy. Foot Ankle Surg. 2012;18:124–7.
27. Maffulli N, Testa V, Capasso G, Bifulco G, Binfield PM. Results of percutaneous
longitudinal tenotomy for Achilles tendinopathy in middle- and long-distance
runners. Am J Sports Med. 1997;25:835–40.
28. Maffulli N, Oliva F, Testa V, Capasso G, Del BA. Multiple percutaneous
longitudinal tenotomies for chronic Achilles tendinopathy in runners: a
long-term study. Am J Sports Med. 2013;41:2151–7.
29. Cottom JM, Hyer CF, Berlet GC, Lee TH. Flexor hallucis tendon transfer with
an interference screw for chronic Achilles tendinosis: a report of 62 cases.
Foot Ankle Spec. 2008;1:280–7.
30. Duthon VB, Lubbeke A, Duc SR, Stern R, Assal M. Noninsertional Achilles
tendinopathy treated with gastrocnemius lengthening. Foot Ankle Int.
2011;32:375–9.
31. Gurdezi S, Kohls-Gatzoulis J, Solan MC. Results of proximal medial gastrocnemius
release for Achilles tendinopathy. Foot Ankle Int. 2013;34:1364–9.
32. Lohrer H, Nauck T. Results of operative treatment for recalcitrant
retrocalcaneal bursitis and midportion Achilles tendinopathy in athletes.
Arch Orthop Trauma Surg. 2014;134:1073–81.
33. Lui TH. Treatment of chronic noninsertional Achilles tendinopathy with
endoscopic Achilles tendon debridement and flexor hallucis longus transfer.
Foot Ankle Spec. 2012;5:195–200.
34. Maffulli N, Testa V, Capasso G, Oliva F, Sullo A, Benazzo F, et al. Surgery for
chronic Achilles tendinopathy yields worse results in nonathletic patients.
Clin J Sport Med. 2006;16:123–8.
35. Maffulli N, Testa V, Capasso G, Oliva F, Panni AS, Longo UG, et al. Surgery for
chronic Achilles tendinopathy produces worse results in women. Disabil
Rehabil. 2008;30:1714–20.
36. Maquirriain J, Ayerza M, Costa-Paz M, Muscolo DL. Endoscopic surgery in
chronic achilles tendinopathies: A preliminary report. Arthroscopy.
2002;18:298–303.
37. Martin RL, Manning CM, Carcia CR, Conti SF. An outcome study of chronic
Achilles tendinosis after excision of the Achilles tendon and flexor hallucis
longus tendon transfer. Foot Ankle Int. 2005;26:691–7.
Lohrer et al. BMC Musculoskeletal Disorders  (2016) 17:207 Page 9 of 10
38. Ruergård A, Alfredson H. Major physical but also psychological effects after
pain relief from surgical scraping in patients with Achilles tendinopathy -
A 1-year follow-up study. Pain Stud Treat. 2014;2:21–5.
39. Thermann H, Benetos IS, Panelli C, Gavriilidis I, Feil S. Endoscopic treatment
of chronic mid-portion Achilles tendinopathy: novel technique with
short-term results. Knee Surg Sports Traumatol Arthrosc. 2009;17:1264–9.
40. Vega J, Cabestany JM, Golano P, Perez-Carro L. Endoscopic treatment for
chronic Achilles tendinopathy. Foot Ankle Surg. 2008;14:204–10.
41. Wilcox DK, Bohay DR, Anderson JG. Treatment of chronic achilles tendon
disorders with flexor hallucis longus tendon transfer/augmentation. Foot
Ankle Int. 2000;21:1004–10.
42. Maquirriain J. Surgical treatment of chronic achilles tendinopathy: long-term
results of the endoscopic technique. J Foot Ankle Surg. 2013;52:451–5.
43. Wiegerinck JI, Kok AC, van Dijk CN. Surgical treatment of chronic
retrocalcaneal bursitis. Arthroscopy. 2012;28:283–93.
44. Wiegerinck JI, Kerkhoffs GM, van Sterkenburg MN, Sierevelt IN, van Dijk CN.
Treatment for insertional Achilles tendinopathy: a systematic review.
Knee Surg Sports Traumatol Arthrosc. 2013;21:1345–55.
45. Zwiers R, Wiegerinck JI, van Dijk CN. Treatment of midportion Achilles
tendinopathy: an evidence-based overview. Knee Surg Sports Traumatol
Arthrosc. 2014. [Epub ahead of print]
46. Huskisson EC. Measurement of pain. Lancet 1974;304:1127–31.
47. Iversen JV, Bartels EM, Langberg H. The victorian institute of sports
assessment - achilles questionnaire (visa-a) - a reliable tool for measuring
achilles tendinopathy. Int J Sports Phys Ther. 2012;7:76–84.
48. Kitaoka HB, Alexander IJ, Adelaar RS, Nunley JA, Myerson MS, Sanders M.
Clinical rating systems for the ankle-hindfoot, midfoot, hallux, and lesser
toes. Foot Ankle Int. 1994;15:349–53.
49. Robinson JM, Cook JL, Purdam C, Visentini PJ, Ross J, Maffulli N, et al. The
VISA-A questionnaire: a valid and reliable index of the clinical severity of
Achilles tendinopathy. Br J Sports Med. 2001;35:335–41.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Lohrer et al. BMC Musculoskeletal Disorders  (2016) 17:207 Page 10 of 10
